{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:05:11Z","timestamp":1789383911235,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973155"],"award-info":[{"award-number":["81973155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["81973155"],"award-info":[{"award-number":["81973155"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Objectives: Candidate estrogen receptor alpha (ER\u03b1) antagonists should combine strong inhibitory activity with favorable absorption, distribution, metabolism, excretion, and toxicity (ADMET)-related properties. This study developed an integrated framework for multi-endpoint prediction, multi-objective optimization in molecular descriptor space, and prioritization of feasible solutions. Methods: A dataset of 1974 compounds with 729 molecular descriptors, pIC50 values, and five binary ADMET-related endpoints was analyzed. Key descriptors were identified through two-stage cross-method and cross-endpoint screening. One regression model for pIC50 and five independent classification models for the ADMET-related endpoints were developed and evaluated separately. The final selected models were incorporated into a two-phase hybrid adaptive multi-objective evolutionary algorithm (2P-HAMOEA). Feasible Pareto solutions were ranked using objective weighting, multi-criteria decision-making, reliability-based fusion, and a performance uncertainty index-based adjustment. Results: The final dataset comprised 1875 compounds and 24 key molecular descriptors. The three-model stacking ensemble for pIC50 achieved an R2 of 0.650 in the internal holdout set, and the AUC values of the five ADMET models ranged from 0.878 to 0.979. Under the prespecified criteria, 2P-HAMOEA generated 155 feasible Pareto solutions. Its generational distance was significantly lower than that of four comparator algorithms, whereas its inverted generational distance and hypervolume were not superior to those of most comparators. pIC50 received the highest fused weight (0.328), and pairwise rank correlations among TOPSIS, VIKOR, and WASPAS exceeded 0.90. The top 20% of RWS-ranked solutions (n = 31) were used for descriptor-interval analysis. Conclusions: The framework offers an early-stage, descriptor-level way to examine endpoint-specific predictions before alternative multi-endpoint profiles are compared. The Pareto solutions are numerical descriptor profiles rather than explicit or experimentally validated ER\u03b1 antagonist structures; independent validation and molecular structure generation remain necessary.<\/jats:p>","DOI":"10.3390\/ph19091453","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:19:41Z","timestamp":1789381181000},"page":"1453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-Endpoint Prediction of Bioactivity and ADMET Properties Coupled with Multi-Objective Optimization in Molecular Descriptor Space for Candidate ER\u03b1 Antagonists"],"prefix":"10.3390","volume":"19","author":[{"given":"Yu","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Health Statistics, School of Public Health, Shanxi Medical University, Jinzhong 030600, China"},{"name":"Shanxi Key Laboratory of Biomedical Data and Statistics, Shanxi Medical University, Jinzhong 030600, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Yuchao","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Health Statistics, School of Public Health, Shanxi Medical University, Jinzhong 030600, China"},{"name":"Shanxi Key Laboratory of Biomedical Data and Statistics, Shanxi Medical University, Jinzhong 030600, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Hao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Health Statistics, School of Public Health, Shanxi Medical University, Jinzhong 030600, China"},{"name":"Shanxi Key Laboratory of Biomedical Data and Statistics, Shanxi Medical University, Jinzhong 030600, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-878X","authenticated-orcid":false,"given":"Lixia","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Health Statistics, School of Public Health, Shanxi Medical University, Jinzhong 030600, China"},{"name":"Shanxi Key Laboratory of Biomedical Data and Statistics, Shanxi Medical University, Jinzhong 030600, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11030-020-10133-y","article-title":"Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer","volume":"25","author":"Kumar","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.1021\/acs.jmedchem.0c00913","article-title":"Selective estrogen receptor degraders (SERDs): A promising strategy for estrogen receptor-positive endocrine-resistant breast cancer","volume":"63","author":"Lu","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.critrevonc.2024.104351","article-title":"Recent strategies to overcome breast cancer resistance","volume":"197","author":"Khan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Belachew, E.B., and Sewasew, D.T. (2021). Molecular mechanisms of endocrine resistance in estrogen-positive breast cancer. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.599586"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, X., Tang, L., Li, Z., Qiu, D., Yang, Z., and Li, B. (2023). Prediction of ADMET properties of anti-breast-cancer compounds using three machine-learning algorithms. Molecules, 28.","DOI":"10.3390\/molecules28052326"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/acs.jcim.8b00785","article-title":"Predictive multitask deep neural network models for ADME-Tox properties: Learning from large datasets","volume":"59","author":"Wenzel","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: Where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/acs.molpharmaceut.2c00962","article-title":"Systematic evaluation of local and global machine-learning models for the prediction of ADME properties","volume":"20","author":"Gerebtzoff","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3934\/mbe.2023237","article-title":"Optimal modeling of anti-breast-cancer candidate drug screening based on multimodel ensemble learning with imbalanced data","volume":"20","author":"Zhou","year":"2023","journal-title":"Math. Biosci. Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2174\/138955712802762284","article-title":"Multi-objective optimization methods in de novo drug design","volume":"12","author":"Nicolaou","year":"2012","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Angelo, J.S., Guedes, I.A., Barbosa, H.J.C., and Dardenne, L.E. (2023). Multi- and many-objective optimization: Present and future in de novo drug design. Front. Chem., 11.","DOI":"10.3389\/fchem.2023.1288626"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.sbi.2023.102537","article-title":"Artificial intelligence in multi-objective drug design","volume":"79","author":"Luukkonen","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100678","DOI":"10.1016\/j.patter.2023.100678","article-title":"Computer-aided multi-objective optimization in small-molecule discovery","volume":"4","author":"Fromer","year":"2023","journal-title":"Patterns"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19347","DOI":"10.1038\/s41598-022-23851-0","article-title":"Application of multi-objective optimization in the study of anti-breast-cancer candidate drugs","volume":"12","author":"Mei","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1080\/02648725.2023.2193484","article-title":"Optimization modeling of anti-breast-cancer candidate drugs","volume":"40","author":"Zhou","year":"2024","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17433","DOI":"10.1109\/TNNLS.2025.3569893","article-title":"Multigranularity fuzzy autoencoder for discriminative feature selection in high-dimensional data","volume":"36","author":"Chen","year":"2025","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jbmr\/zjaf105","article-title":"Emerging applications of feature selection in osteoporosis research: From biomarker discovery to clinical decision support","volume":"40","author":"Wang","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1109\/TNSRE.2020.3034234","article-title":"Feature-selection-based transfer learning for intracortical brain\u2013machine interface decoding","volume":"29","author":"Zhang","year":"2021","journal-title":"IEEE Trans. Neural Syst. Rehabil. Eng."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dong, Z., Chen, H., Yang, Y., and Hao, H. (2025). Research on the optimization model of anti-breast cancer candidate drugs based on machine learning. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1523015"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/HEP.0000000000000628","article-title":"An entropy weight method to integrate big omics and mechanistically evaluate drug-induced liver injury","volume":"79","author":"Jin","year":"2024","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41746-025-01643-w","article-title":"Artificial intelligence-based multispecialty mortality prediction models for septic shock in a multicenter retrospective study","volume":"8","author":"Wang","year":"2025","journal-title":"npj Digit. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e21256","DOI":"10.1016\/j.heliyon.2023.e21256","article-title":"Design and evaluation of a sustainable entropy-weighted and VIKOR-based method for offshore oil collecting","volume":"9","author":"Luo","year":"2023","journal-title":"Heliyon"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"119288","DOI":"10.1016\/j.watres.2022.119288","article-title":"A VIKOR-based approach to evaluate river contamination risks caused by wastewater treatment plant discharges","volume":"226","author":"Shen","year":"2022","journal-title":"Water Res."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:36:50Z","timestamp":1789382210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091453"],"URL":"https:\/\/doi.org\/10.3390\/ph19091453","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}